Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹423.75
Market cap: ₹4,249 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.9×Sector 50.4×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Management Change 1 Legal & Regulatory 1 Financial Results 1 Credit Rating 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

17 Aug 2026 18:31 IST BSE

Earnings Call

Gufic BioSciences Earnings Call Transcript: Key Takeaways

Gufic reports strong Q1 FY27 growth, driven by Indore plant ramp-up and expansion into high-margin complex injectables like GLP-1 (Semaglutide) and Botulinum Toxin.

Call: Guides 15% growth

Open call summary → Read the filing ↗

14 Aug 2026 20:17 IST BSE

Earnings Call

Gufic BioSciences Investor Presentation: Key Takeaways

Gufic reported Q1 FY27 revenue of ₹260.8 Cr (+15% YoY) with EBITDA margins expanding to 18.09%. Strategy pivots toward IP-owned complex injectables and scaling the new Indore facility.

Open call summary → Read the filing ↗